Dow Up Over 400 Points as Wall Street Pores Over Earnings

Johnson & Johnson's earnings are boosting the blue-chip index

Deputy Editor
Apr 19, 2022 at 12:02 PM
facebook X logo linkedin

Stocks are pointed higher this afternoon, as Wall Street pores over the latest batch of quarterly reports amid one of the busiest weeks of earnings season. The Dow Jones Industrial Average (DJI) boasts a triple-digit lead, up 400 points at midday after being boosted by blue-chip component Johnson & Johnson's (JNJ) first-quarter results. Meanwhile, the S&P 500 Index (SPX) and Nasdaq Composite (IXIC) are also sporting comfortable gains at the halfway mark. March's housing starts and building permits data came in today as well, and both beat analysts' expectations.

Continue reading for more on today's market, including: 

  • Cassava Sciences' Alzheimer's drug raises new concerns.
  • This logistics concern's strong earnings report attracted a host of attention.
  • Plus, options traders respond to AXSM's FDA hopes; pharmaceutical stock's acquisition news; and NetGear's lackluster preliminary results.

Midday Market Stats April 19_2022

Axsome Therapeutics Inc (NASDAQ:AXSM) is trading at $38.53, up a staggering 17.9% at midday after the company said it expects the U.S. Food and Drug Administration (FDA) to take action on its depression drug application AXS-05 in the near future. Options traders are taking note, with 4,355 calls and 3,956 puts exchanged so far, which is six times the amount typically seen at this point. The most activity is occurring at the May 25 and 20 puts. The shares are on track to snap an eight-day losing streak, which culminated in yesterday's close below the 200-day moving average. Year-to-date, Axsome Therapeutics stock is up 4.3%.

AXSM Chart April 19

The best performing stock on the Nasdaq so far today is Checkmate Pharmaceuticals Inc (NASDAQ:CMPI), and it's not even close. The equity was last seen up 332.8% to trade at $10.43, following news that Regeneron Pharmaceuticals (REGN) is acquiring the company for about $250 million. CMPI is trading at its highest level in a year as a result, and now sports a 263.4% year-to-date lead.

NetGear, Inc. (NASDAQ:NTGR), meanwhile, is pacing near the bottom of the index after reporting weaker-than-expected preliminary results for the first quarter and slashing its current-quarter revenue forecast. As a result, NTGR was last seen down 6.7% to trade at $21.59 -- its lowest level since the broader market's March 2020 pullback. Year-over-year, NetGear stock is down 44.2%.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI